Shanmu

Shanmu (杉木) is a Chinese medical robotics company developing AI-powered, ultra-miniaturized home health monitoring devices. Its core product, the SHANMU S1, is a toilet-mounted robot that performs automated, non-invasive urine analysis using microfluidic chipsets and multi-spectral sensors to quantify over 10 biomarkers for chronic disease management. The company was named to the Forbes China AI TOP 50 in 2026 and won a CES 2025 Innovation Award in Digital Health.

Shanmu has 1 robot model on the DEPLOY registry: Shanmu Robot (Shanmu builds physical robots).

No. Shanmu is privately held and not publicly traded, per the DEPLOY registry.

Lin Hequan is the ceo of Shanmu, per the DEPLOY registry.

Shanmu is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today. It has raised $44M in disclosed funding.

Shanmu is headquartered in Shenzhen, Guangdong, China.

Shanmu has raised approximately $44M in disclosed funding on record in the DEPLOY registry.

Shanmu is privately held and venture-backed ($44M raised); ownership sits with its founders and private investors.

Shanmu is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Shanmu ranks in roughly the top 23% of companies tracked by the registry.

Shanmu was founded in 2021.

Shanmu has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.